Table of Contents
Afrezza is an inhalable insulin used by many people with diabetes to help control blood sugar levels. While it offers convenience and rapid action, it also carries a risk of hypoglycemia, or low blood sugar. Managing this risk is essential for safe and effective treatment.
Understanding Hypoglycemia and Afrezza
Hypoglycemia occurs when blood sugar drops below normal levels, causing symptoms like shakiness, sweating, confusion, and in severe cases, loss of consciousness. Afrezza’s rapid absorption can sometimes lead to unexpected drops in blood sugar if not carefully managed.
Tips for Managing Hypoglycemia Risks
- Monitor Blood Sugar Regularly: Check your blood glucose levels frequently, especially after starting Afrezza or adjusting doses.
- Adjust Your Diet: Consume balanced meals with appropriate carbohydrate intake to prevent sudden drops.
- Carry Fast-Acting Carbohydrates: Always have glucose tablets or sugary snacks nearby in case of hypoglycemia.
- Educate Yourself and Others: Learn to recognize early symptoms and inform family or friends about how to help if needed.
- Follow Your Healthcare Provider’s Instructions: Use Afrezza exactly as prescribed and attend regular check-ups.
When to Seek Medical Help
If you experience severe hypoglycemia symptoms such as confusion, seizures, or loss of consciousness, seek emergency medical assistance immediately. Do not attempt to drive or operate machinery until your condition stabilizes.
Conclusion
Managing hypoglycemia risks while using Afrezza involves vigilant blood sugar monitoring, proper diet, and awareness of symptoms. Collaborate closely with your healthcare team to develop a personalized plan that ensures safe and effective diabetes management.